Success Metrics

Clinical Success Rate
92.5%

Based on 37 completed trials

Completion Rate
93%(37/40)
Active Trials
24(27%)
Results Posted
14%(5 trials)
Terminated
3(3%)

Phase Distribution

Ph not_applicable
26
29%
Ph phase_2
4
4%
Ph early_phase_1
1
1%
Ph phase_1
2
2%
Ph phase_4
3
3%

Phase Distribution

3

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution36 total trials
Early Phase 1First-in-human
1(2.8%)
Phase 1Safety & dosage
2(5.6%)
Phase 2Efficacy & side effects
4(11.1%)
Phase 4Post-market surveillance
3(8.3%)
N/ANon-phased studies
26(72.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.4%

37 of 46 finished

Non-Completion Rate

19.6%

9 ended early

Currently Active

24

trials recruiting

Total Trials

90

all time

Status Distribution
Active(29)
Completed(37)
Terminated(9)
Other(15)

Detailed Status

Completed37
Recruiting16
unknown14
Active, not recruiting8
Withdrawn6
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
90
Active
24
Success Rate
92.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.8%)
Phase 12 (5.6%)
Phase 24 (11.1%)
Phase 43 (8.3%)
N/A26 (72.2%)

Trials by Status

active_not_recruiting89%
terminated33%
unknown1416%
recruiting1618%
suspended11%
withdrawn67%
completed3741%
not_yet_recruiting22%
enrolling_by_invitation33%

Recent Activity

Clinical Trials (90)

Showing 20 of 90 trialsScroll for more
NCT07555925Not Applicable

RELIEVE METAB Study

Not Yet Recruiting
NCT07549477Not Applicable

A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With Cancer

Recruiting
NCT06770062

Multimodality Evaluation of Left Ventricular Remodeling In Mitral Regurgitation: A Pilot Study

Recruiting
NCT03498001Not Applicable

Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging

Completed
NCT05164744

Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors

Recruiting
NCT03746964

Prospective Evaluation of the Biomechanical Properties of the Thoracic Aorta Coupling Magnetic Resonance Imaging and In-vitro Elasticity Tests in Patients With Ascending Aortic Aneurysm

Recruiting
NCT01671696

Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy

Completed
NCT07131631

Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance

Recruiting
NCT05930418Not Applicable

Cardiovascular Magnetic Resonance Prognosticators in Pediatric Oncology Patients With Sepsis

Active Not Recruiting
NCT06073574

CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study

Active Not Recruiting
NCT02728336Not Applicable

MRI Assessment of Patient Suitability for Cardiac Resynchronization Therapy (CRT)

Suspended
NCT05558813Not Applicable

Natural History of Duchenne Muscular Dystrophy Cardiomyopathy (DMD-CMP)

Withdrawn
NCT04790266

Early Detection of Cardiotoxicity From Systemic and Radiation Therapy in Breast Cancer Patients

Completed
NCT02791581Not Applicable

Understanding and Predicting Breast Cancer Events After Treatment

Active Not Recruiting
NCT03345446

Circulating RNAs in Acute Congestive Heart Failure

Active Not Recruiting
NCT04036045

Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity

Withdrawn
NCT06605833

CARDiac Toxicity Following ImmunOtherapy Treatment for Melanoma

Enrolling By Invitation
NCT00832702

Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction

Active Not Recruiting
NCT06409585

Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition

Recruiting
NCT07125040

Characterization of the Natural History of LAMA2-RD and Identification of Novel Disease Biomarkers

Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
90